Facial Injectable Market Market Set to Exceed USD 18,819.04 Million by 2026
Forecast to 2020
Facial Injectable Market Size is Estimated to Reach USD 18,819.04 Million by 2026
“Facial Injectable Market [By Products (Dermal Fillers/Injectable Implants and Antiaging/ Anti-wrinkle Injections); By End Users (Hospitals, Dermatology Clinics, Beauty Clinics, and Dermatology Research Institutes); and by Regions]: Market size & Forecast, 2018 – 2026� The Global Facial Injectable Market is anticipated to reach over USD 18,819.04 Million by 2026 according to a new research published by Polaris Market Research. Facial injectable products also called as dermal fillers are products that benefit in facial transformation. These facial injectable products are widely used to indulgence the early signs of age as well as wrinkles thereby increasing the visual attractiveness. Factors such as the rise in demand to augment the visual look and growing popularity for negligibly intrusive procedures majorly drive the market. In addition, the rise in elderly population and introduction of improved facial injectable such as synthetic calcium hydroxyl apatite fillers further anticipated boosting the market growth. In recent time, growing demand for non-surgical processes for facial transformation and modification is gaining global admiration. For instance, according to the International Society of Aesthetic Plastic Surgery (ISAPS), 2017, non-surgical and surgical cosmetic techniques showed an overall rise of 9% from past years. Moreover, according to the same report in 2016, nonsurgical procedures including injectable accounted for approximately 8 million globally. The global Facial Injectable Market is segmented on the basis of products, end users, and geography. a stringent regulatory scenario may lower growth
in market for the devices. Browse Detailed Research Report On Facial Injectable Market: https://www.polarismarketresearch.com/industry-analysis/global-facial-injectable-market On the basis of products, the Global Facial Injectable Market is segmented into Dermal Fillers/Injectable Implants and Anti-aging/ Anti-wrinkle Injections. The Dermal Fillers/Injectable Implants is further segmented into Hyaluronic Acid, Collagen Fillers, and Synthetic Fillers such as Calcium hydroxylapatite and polymethyl methacrylate microspheres. The Anti-aging/ Anti-wrinkle Injections is further categorized into Botulinum toxin A and Poly-L-lactic acid (PLLA) micro particles. On the basis of products, the hyaluronic acid segment is estimated to dominate the market in 2017. Moreover, this segment is anticipated to show lucrative growth during the forecast period. Cumulative use of hyaluronic acid as a dermal filler in the cosmetic procedure is anticipated to support the market growth. Hyaluronic acid has become an important part of cosmetics and aesthetic surgeries due to its robust water retaining properties. In general, the cosmetic-grade hyaluronic acid has the lower molecular weight which further aids to retain water in the cells, releases antioxidants, form the deep penetration of the product in the epidermis, and delays the aging progression. On the basis of the end user, the global Facial Injectable Market is segmented into Hospitals, Dermatology Clinics, Beauty Clinics, and Dermatology Research Institutes. In 2017, hospital segment is estimated to dominate the global market. -2-
Facial Injectable Market Size is Estimated to Reach USD 18,819.04 Million by 2026
Some major key players in global Facial Injectable Market include Advanced Dermatology, Merz, Inc., Galderma Laboratories, L.P., ColBar LifeScience Ltd., Allergan, Plc., Valeant Pharmaceuticals North America LLC., Sanofi Biosurgery Inc. (Sanofi), Anika Therapeutics, Inc., Suneva Medical, Inc.among others.
Request for sample: https://www.polarismarketresearch.com/industry-analysis/global-facialinjectable-market/request-for-sample
Table of Contents 1. Overview and Scope 1.1. Research goal & scope 1.2. Research assumptions 1.3. Research Methodology 1.3.1. Primary data sources 1.3.2. Secondary data sources 1.4. Key take-aways 1.5. Stakeholders 2. Executive Summary 2.1. Market Definition 2.2. Market Segmentation 3. Facial Injectable Market Insights 3.1. Facial Injectable – Industry snapshot 3.2. Facial Injectable - Ecosystem analysis 3.3. Facial Injectable Market dynamics 3.3.1. Facial Injectable – Market Forces 3.3.1.1. Facial Injectable Market driver analysis 3.3.1.2. Facial Injectable Market restraint/challenges analysis 3.3.1.3. Facial Injectable Market opportunity analysis -3-
Facial Injectable Market Size is Estimated to Reach USD 18,819.04 Million by 2026
3.3.2. Industry analysis - Porter's five force 3.3.2.1. Bargaining power of supplier 3.3.2.2. Bargaining power of buyer 3.3.2.3. Threat of substitute 3.3.2.4. Threat of new entrant 3.3.2.5. Degree of competition 3.3.3. Facial Injectable Market PEST analysis, 2017 3.3.4. Facial Injectable Industry trends 3.3.5. Competitive Ranking Analysis 4. Facial Injectable Market Size and Forecast by Product 4.1. Key findings 4.2. Dermal Fillers/Injectable Implants 4.2.1. Global market estimates and forecasts, 2017 – 2026 4.2.1.1. Hyaluronic Acid 4.2.1.2. Collagen Fillers 4.2.1.3. Synthetic Fillers 4.2.2. Anti-aging/ Anti-wrinkle Injections 4.2.2.1. Global market estimates and forecasts, 2017 – 2026 4.2.2.1.1. Botulinum toxin A 4.2.2.1.2. Poly-L-lactic acid (PLLA) micro particles 5. Facial Injectable Market Size and Forecast by End User 5.1. Key findings 5.2. Hospitals 5.2.1. Global market estimates and forecasts, 2017 - 2026 5.3. Dermatology Clinics 5.3.1. Global market estimates and forecasts, 2017 – 2026 5.4. Beauty Clinics 5.4.1. Global market estimates and forecasts, 2017 – 2026 5.5. Dermatology Research Institutes 5.5.1. Global market estimates and forecasts, 2017 – 2026 6. Facial Injectable Market Size and Forecast by Regions 6.1. Key findings 6.2. North America 6.2.1. Facial Injectable Market by Products, 2017 - 2026 6.2.2. Facial Injectable Market by End Users, 2017 - 2026 6.2.3. U.S. 6.2.3.1. Facial Injectable Market by Products, 2017 - 2026 6.2.3.2. Facial Injectable Market by End Users, 2017 - 2026 6.2.4. Canada 6.2.4.1. Facial Injectable Market by Products, 2017 - 2026 6.2.4.2. Facial Injectable Market by End Users, 2017 - 2026 6.3. Europe 6.3.1. Facial Injectable Market by Products, 2017 - 2026 6.3.2. Facial Injectable Market by End Users, 2017 - 2026 6.3.3. Germany 6.3.3.1. Facial Injectable Market by Products, 2017 - 2026 6.3.3.2. Facial Injectable Market by End Users, 2017 - 2026 6.3.4. UK 6.3.4.1. Facial Injectable Market by Products, 2017 - 2026 6.3.4.2. Facial Injectable Market by End Users, 2017 - 2026 6.3.5. France 6.3.5.1. Facial Injectable Market by Products, 2017 - 2026 6.3.5.2. Facial Injectable Market by End Users, 2017 - 2026 6.3.6. Italy 6.3.6.1. Facial Injectable Market by Products, 2017 - 2026 6.3.6.2. Facial Injectable Market by End Users, 2017 - 2026 6.4. Asia Pacific -4-
Facial Injectable Market Size is Estimated to Reach USD 18,819.04 Million by 2026
6.4.1. Facial Injectable Market by Products, 2017 - 2026 6.4.2. Facial Injectable Market by End Users, 2017 - 2026 6.4.3. China 6.4.3.1. Facial Injectable Market by Products, 2017 - 2026 6.4.3.2. Facial Injectable Market by End Users, 2017 - 2026 6.4.4. India 6.4.4.1. Facial Injectable Market by Products, 2017 - 2026 6.4.4.2. Facial Injectable Market by End Users, 2017 - 2026 6.4.5. Japan 6.4.5.1. Facial Injectable Market by Products, 2017 - 2026 6.4.5.2. Facial Injectable Market by End Users, 2017 - 2026 6.4.6. Australia 6.4.6.1. Facial Injectable Market by Products, 2017 - 2026 6.4.6.2. Facial Injectable Market by End Users, 2017 - 2026 6.5. Latin America 6.5.1. Facial Injectable Market by Products, 2017 - 2026 6.5.2. Facial Injectable Market by End Users, 2017 - 2026 6.5.3. Brazil 6.5.3.1. Facial Injectable Market by Products, 2017 - 2026 6.5.3.2. Facial Injectable Market by End Users, 2017 - 2026 6.5.4. Mexico 6.5.4.1. Facial Injectable Market by Products, 2017 - 2026 6.5.4.2. Facial Injectable Market by End Users, 2017 - 2026 6.6. Middle East & Africa 6.6.1. Facial Injectable Market by Products, 2017 - 2026 6.6.2. Facial Injectable Market by End Users, 2017 - 2026 7. Company Profiles 7.1. Advanced Dermatology 7.1.1. Overview 7.1.2. Financials 7.1.3. Product Benchmarking 7.1.4. Recent Developments 7.2. Merz, Inc. 7.2.1. Overview 7.2.2. Financials 7.2.3. Product Benchmarking 7.2.4. Recent Developments 7.3. Galderma Laboratories, L.P. 7.3.1. Overview 7.3.2. Financials 7.3.3. Product Benchmarking 7.3.4. Recent Developments 7.4. ColBar LifeScience Ltd. 7.4.1. Overview 7.4.2. Financials 7.4.3. Product Benchmarking 7.4.4. Recent Developments 7.5. Allergan, Plc. 7.5.1. Overview 7.5.2. Financials 7.5.3. Product Benchmarking 7.5.4. Recent Developments 7.6. Valeant Pharmaceuticals North America LLC. 7.6.1. Overview 7.6.2. Financials 7.6.3. Product Benchmarking 7.6.4. Recent Developments -5-
Facial Injectable Market Size is Estimated to Reach USD 18,819.04 Million by 2026
7.7. Sanofi Biosurgery Inc. (Sanofi) 7.7.1. Overview 7.7.2. Financials 7.7.3. Product Benchmarking 7.8. Anika Therapeutics, Inc. 7.8.1. Overview 7.8.2. Financials 7.8.3. Product Benchmarking 7.8.4. Recent Developments 7.9. Suneva Medical, Inc. 7.9.1. Overview 7.9.2. Financials 7.9.3. Product Benchmarking 7.9.4. Recent Developments
Access Press Release on Facial Injectable Market: https://www.polarismarketresearch.com/press-releases/global-facial-injectable-market
About Polaris Market Research Polaris Market Research is a global market research and consulting company. The company specializes in providing exceptional market intelligence and in-depth business research services for our clientele spread across different enterprises. We at Polaris are obliged to serve our diverse customer base present across the industries of healthcare, technology, semi-conductors and chemicals among various other industries present around the world. We strive to provide our customers with updated information on innovative technologies, high growth markets, emerging business environments and latest business-centric applications, thereby helping them always to make informed decisions and leverage new opportunities. Adept with a highly competent, experienced and extremely qualified team of experts comprising SMEs, analysts and consultants, we at Polaris endeavor to deliver value-added business solutions to our customers. E mail Id: sales@polarismarketresearch.com Web: www.polarismarketresearch.com Official Blog: http://healthcare-market-insights.blogspot.com/
-6-
Facial Injectable Market Size is Estimated to Reach USD 18,819.04 Million by 2026
-7-
